Tag: PreveCeutical Medical Inc.

September 3, 2019

PreveCeutical Reaches Milestone in Research Program for Development of Non-Addictive Analgesics

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has recently reached a significant...
August 6, 2019

PreveCeutical Grants Asterion Option to Purchase up to a 51% Interest in Sol-Gel Intellectual Property

PreveCeutical Medical Inc. (CSE: PREV) grants Asterion option to purchase up to a 51% Interest in Sol-Gel Intellectual Property
July 9, 2019

PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System

PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System
June 21, 2019

PreveCeutical Announces Appointment of New Directors

PreveCeutical Medical Inc. (CSE:PREV), is pleased to announce the appointments of Keith Anderson and Mark Lotz to the board of...
June 17, 2019

PreveCeutical Announces Further Positive Results from its Dual Gene Therapy Research Program

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide positive results from...
June 3, 2019

PreveCeutical Secures $300,000 Loan and Resignation of a Director

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H)(the "Company" or "PreveCeutical") announces that it has received a loan in the aggregate amount...
May 21, 2019

PreveCeutical Granted Approval to Acquire and Use Human Mucosal Tissue for Final Phase of Sol-Gel Program

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), announces that the Company's research team at the University of...